4 terminated, 2 completed, 1 suspended. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 4, Completed 2, Suspended 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow glucarpidase: new trials by email Literature Review of glucarpidase trials Research Report on glucarpidase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS Glucarpidase 1000 UNT [Voraxaze] - Diffuse Large B-Cell Lymphoma, Drug Toxicity | Phase 2 | Terminated | Fundacion CRIS de Investigación para Vencer el Cáncer | 3 | 2021-07-19 | 2024-05-13 |
| HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma Glucarpidase - Lymphoma | Phase 2 | Suspended | Fox Chase Cancer Center | 3 | 2021-04-16 | 2024-03-22 |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma glucarpidase, leucovorin - Osteosarcoma | Phase 2 | Terminated | BTG International Inc. | 7 | 2008-10-01 | 2014-09-15 |
| Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma glucarpidase, leucovorin calcium, methotrexate - Chemotherapeutic Agent Toxicity, Lymphoma | Phase 1 / Phase 2 | Completed | University College, London | 4 | 2008-07-01 | 2014-01-27 |
| Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? Glucarpidase, Methotrexate, Folinic Acid - Osteosarcoma, Spindle Cell Sarcoma of Bone | Phase 2 | Terminated | University College, London | 34 | 2007-07-01 | 2015-06-04 |
| Voraxaze for Delayed Methotrexate Clearance Voraxaze (Glucarpidase), Placebo - Hematologic Malignancy, Solid Tumor | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 3 | 2007-01-01 | 2012-12-06 |
| Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance glucarpidase (50 Units/kg) - Neoplasms | Phase 2 | Completed | BTG International Inc. | 2000-01-01 | 2014-09-11 |
Lymphoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Mucositis (2) · Osteosarcoma (2) · Drug-Related Side Effects and Adverse Reactions (1) · Hematologic Neoplasms (1) · Neoplasms (1) · Neurotoxicity Syndromes (1) · Renal Insufficiency (1)
BTG International Inc. (2) · University College, London (2) · Fox Chase Cancer Center (1) · Fundacion CRIS de Investigación para Vencer el Cáncer (1) · M.D. Anderson Cancer Center (1)
United Kingdom (2) · United States (2) · Germany (1) · Spain (1)
Adolfo De la Fuente, PD (1) · Jeremy Whelan, Professor (1) · Pete Anderson, MD, PhD (1) · Roderick Johnson, MD (1) · Saroj Vadhan-Raj, MD (1) · Thiel Eckhard, Prof. Dr.med. (1)